Cerebral Therapeutics announces enrolment of first patient in phase 2b trial in epilepsy

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 18, 2020 at 12:02 PM.

  1. #1 cafead, Nov 18, 2020 at 12:02 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,973
    Likes Received:
    3
    via Cerebral Therapeutics announced that the first patient has been enrolled in a Phase 2b study of intracerebroventricular drug delivery of the anti-seizure medication CT-010 in patients with medically refractory epilepsy.

    article source
     
    Quote

Reply to Thread